Director at $CME sells 300 shares in insider sale

03 SHARES AND 2 SALES selling 768 for an estimated $200,072.WILLIAM R SHEPARD has made 4 purchases buying 536 shares for an estimated $145,679 and 0 sales.TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475MARTIN J GEPSMAN sold 300 shares for an estimated $91,770

To monitor insider transactions, one can visit Quiver Quantitative’s insider trading dashboard.

In terms of hedge fund activity, there have been notable movements in $CME stock. While 832 institutional investors have added shares of $CME to their portfolio, 802 have reduced their positions in the most recent quarter. Some of the significant recent changes include UBS AM, a unit of UBS Asset Management Americas LLC, removing 7,716,211 shares from their portfolio in Q4 2025, Victory Capital Management Inc adding 1,807,491 shares to their portfolio, and JPMorgan Chase & Co increasing their position by 1,559,916 shares.

When it comes to revenue, $CME reported revenues of $1.6B in Q4 2025, reflecting an 8.09% increase from the same period in the previous year. Those interested in tracking CME’s financials can do so on Quiver Quantitative’s CME stock page.

In the realm of Congressional stock trading, members have engaged in transactions related to $CME stock. Four trades have occurred in the last 6 months, with 1 purchase and 3 sales. Representative Gilbert Ray Cisneros, Jr. made a purchase of up to $15,000 on 01/09, while Representative Julie Johnson conducted 2 sales worth up to $30,000 on 11/13 and 12/18.

Various Wall Street analysts have offered their insights on $CME in recent months. Notably, 4 firms have issued buy ratings on the stock, while 1 firm has issued a sell rating. Analysts at Piper Sandler, Morgan Stanley, Deutsche Bank, JP Morgan, and Citigroup have presented their views on the stock.

Moreover, multiple analysts have put forward price targets for $CME recently, with a median target of $307.0. Analysts from Barclays, RBC Capital, Morgan Stanley, JPMorgan, TD Cowen, and Piper Sandler have provided price targets for the stock.

It is important to note that this article is not financial advice and readers should refer to Quiver Quantitative’s disclaimers for more information.